Patterson Companies, INC

Patterson Companies, a leading supplier in the dental and animal health markets, has been acquired by Patient Square Capital, leading to Robert Rajalingam's appointment as the new CEO, effective April 17, 2025.

Patterson Companies, Inc. has completed its acquisition by Patient Square Capital, resulting in the company becoming a private entity and delisting from the NASDAQ.

Patterson Companies' shareholders have approved the acquisition of the company by Patient Square Capital at a special meeting held on April 1, 2025.

Patterson Companies amends its proxy statement to address shareholder lawsuits alleging inadequate disclosures regarding its merger with Paradigm Parent, LLC, aiming to avoid delays and minimize legal expenses.

Patterson Companies' Q3 fiscal 2025 results reveal a decrease in net sales and earnings, impacted by market challenges and a cybersecurity attack, as the company progresses towards its acquisition by Patient Square Capital.

Patterson Companies announces the expiration of its go-shop period with no alternative acquisition proposals received, as the company moves forward with its $4.1 billion acquisition by Patient Square Capital, expected to close in April 2025.

Patterson Companies reports a decrease in net sales for the third quarter of fiscal year 2025, while navigating a pending merger with Patient Square Capital.

Patterson Companies' second quarter of fiscal year 2025 saw a slight increase in net sales but a decrease in profitability, alongside strategic actions including acquisitions and a review of strategic alternatives.

Patterson Companies experienced a decrease in net income for the first quarter of fiscal 2025, primarily due to lower sales and gross margins, and the ongoing impact of a cybersecurity attack on a key service provider.

Patterson Companies experienced a slight increase in net sales but a decrease in net income for the third quarter of fiscal year 2024, primarily due to rising operating expenses.

Patterson Companies, Inc.'s 2024 annual report highlights a year of modest growth amidst a competitive distribution industry, with strategic focus on customer relationships and technological advancements.

Director Pamela J Tomczik reports the disposition of Patterson Companies shares following the completion of a merger, where each share was converted to $31.35 in cash.

Director Neil A. Schrimsher reports the disposition of Patterson Companies shares following the completion of a merger, where each share was converted to $31.35 in cash.

Director Philip McKoy reports the disposition of Patterson Companies shares following the completion of a merger, where each share was converted to $31.35 in cash.

Director Robert Frenzel reports the disposition of Patterson Companies shares following the completion of a merger, where each share was converted into $31.35 in cash.

Director Jody H Feragen reports the disposition of Patterson Companies (PDCO) shares following the completion of a merger, where each share was converted into $31.35 in cash.

Director John D. Buck reports the disposition of Patterson Companies (PDCO) shares following the completion of a merger, where each share was converted to $31.35 in cash.

Patterson Companies updates its proxy statement to address shareholder lawsuits alleging insufficient disclosures regarding the merger with Patient Square Capital, aiming to avoid delays and associated costs.

Patterson Companies, Inc. announces a definitive agreement to be acquired by Paradigm Parent, LLC, an affiliate of Patient Square Capital, for $31.35 per share in cash.

Patterson Companies has filed a preliminary proxy statement regarding its proposed merger with Patient Square Capital, outlining the details of the transaction and the upcoming shareholder vote.

Patterson Companies announced the expiration of the go-shop period related to its acquisition by Patient Square Capital for $31.35 per share, with the transaction expected to close in April 2025.

Patterson Companies has agreed to be acquired by Patient Square Capital for $31.35 per share, with the transaction expected to close in the fourth fiscal quarter of 2025.

Patterson Companies is set to be acquired by a private investment firm, transitioning from public to private ownership.